ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL Angle Plc

13.75
-0.25 (-1.79%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.79% 13.75 13.50 14.00 14.00 13.75 14.00 492,464 12:20:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -1.65 35.83M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £35.83 million. Angle has a price to earnings ratio (PE ratio) of -1.65.

Angle Share Discussion Threads

Showing 32726 to 32748 of 32750 messages
Chat Pages: 1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  1300  1299  Older
DateSubjectAuthorDiscuss
30/4/2024
20:18
Krypton

And anyone also knows there is a mechanism to reduce the nominal value if they can’t get backers at 10p.

The good news is the company value is not crazy. The bad is the likely cash level needed v the share price.

If you have 260m shares in issue (MC £36m) at 14p and need £20m at 10p, that would mean 460m shares, say 11p open making the MC £50m, yet the burn is over 1m per month.

So the claims of below 10p are not fantasy, countless AIM companies have seen share prices destroyed and diluted to oblivion in this market.

Angle fortunately have something of apparent value, but years of lack of uptake will be used as leverage against them to push them lower.

It’s a bad bargaining position start point.

To be concluded in the coming weeks no doubt. Until it’s done everyday (without major deal news) is a gloomy day.

Let’s hope results don’t have any, lower than expected, pushed into 2025 etc as the vultures will have even more discount ammo.

ohwhatfun
30/4/2024
17:49
• NEW RESEARCH in Sheffield to investigate protein that fuels BREAST cancer.• Breast Cancer Now has awarded £250k to Dr Elena Rainero at the UNIVERSITY of SHEFFIELD, to study how BREAST cancer cells use alternative food sources to grow and spread, and the role a protein called a2b1 integrin plays in this process.• This research COULD uncover a cancer-specific process which may lead to the development of treatments that come with fewer side effects for patients, as healthy cells won't be affected.Https://oncologynewstoday.co.uk/new-research-in-sheffield-to-investigate-protein-that-fuels-breast-cancer/-INTERESTINGLY (above):• Will use MOUSE MODELS to block integrin a2b1 with drugs and assess the impact this has on a tumour's growth and spread to other parts of the body – when it spreads the disease becomes INCURABLE secondary BREAST cancer.-MORE INTERESTINGLY:• ANGLE announced in DEC23 research that used the parsortix system in PRE-CLINICAL MOUSE MODELs unlocking OPPORTUNITIES for DRUG DISCOVERY.• This research provides further evidence of the capability of the Parsortix system to be used for the harvesting of CTCs for analysis in pre-clinical mouse models.Https://www.londonstockexchange.com/news-article/AGL/parsortix-unlocks-opportunities-for-drug-discovery/16245716-LASTLY:• It looks as though the University of Sheffield USE and have PARSORTIX. I found a link in their 'equipment catalogue'.Https://equipment.shef.ac.uk/items/739372-
5oletrader
30/4/2024
16:48
Anyone heard of Robert Zeillinger before or any Angle involvement? He appears to have a medical diagnostics company and been involved in funding the above research…
gspanner
30/4/2024
16:35
So worth looking at Mr K’s link…

‘Early access’ via the internet to an EJC article where 473 samples were analysed with parsortix to analyse whether an assay of ESR1 and ERCC1 is predictive
Of response in platinum resistant ovarian cancer. It was!

It’s a helpful example of how parsotix can become mainstream potentially over a number of tumour sites potentially tailoring therapy for millions of patients…

And I would presume the analysis of the 473 patients will hit the bottom line these results… £473k ? (At least)

gspanner
30/4/2024
13:24
Many thanks for the link Mr. K, 'hope all's going well with your treatment.
danwaits
30/4/2024
12:15
You may as well ask your cat.
In fact you'd get a more intelligent reply from it.
Don't engage. Better to discuss more relevant subjects.

boris cobaka
30/4/2024
11:08
If this is such a certainty with regards to a placing, ie, first 14p, then 10p and now 7p.....Why were there no shorts opened against this company?....explain?
htrocka2
30/4/2024
10:08
Credit to KOR on Telegram group.https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978Mr K
mrkeysersoze
30/4/2024
09:48
Why do you keep posting negative comments....are you trying to make money shorting or hope to buy lower. Yes you are. Foolish.No one cares of your opinion. Worthless.
muffster
30/4/2024
08:33
Clearly cr@p financial results expected and more 'jam' tommorrow from Newland with a subtle hint that 'strategic' options include a cash raise but at what price to 'mug' sorry entice investors I'm going 8p!
bones699
30/4/2024
01:12
Chunky delayed buy from Friday put thru first thing. Almost 40k.
Results coming up.

boris cobaka
29/4/2024
21:51
Angle is getting noticed. This is their LinkedIn page.

12,685 Followers.

outsizeclothes.com
29/4/2024
21:20
Timmmmmberrrrrr

Placing anyone ? 7p?

havinthelasttoast
29/4/2024
13:57
Remember the Spanish Inquisition according to Monty Python..........
liberatingsteptoe
29/4/2024
12:52
Yep I sold half at 16p and the rest this morning for circa 10% less. Definitely still interested as I like the company and expect to buy back much lower after what I expect to be underwhelming results and a raise.
adw198
29/4/2024
12:49
For someone who apparently dumped all their shares this morning you seem quite invested in this board LMAO
zeus19
29/4/2024
12:10
If they thought the deals and milestone payments (whatever that means) were likely why wouldn’t they be included in the revenue projection for this year?
adw198
29/4/2024
12:07
And it’s absolutely fine for you to think they won’t need to raise funds because the magic money tree will gift us about 5 times more revenue than we’ve ever achieved. I just think they’ll go to market. One of us will be right.
adw198
29/4/2024
11:45
Angle did not say a placing would be needed

They said there will be a funding short fall to make up

They are looking to fill that with sales, deals and milestone payments etc

They have until early 2025 to do the above

Change the placing theory record because it's getting as boring as you


LOLsss

kryptonsnake
29/4/2024
11:40
Did the company tell you what happens after the 6 months?

What about other deals and sales?

You know nothing


LOLsss

kryptonsnake
29/4/2024
11:39
The 'shareholder/institutional placing' experts ignore one blatantly obvious fact: - there are more ways than 1 of raising cash.
What if some company, like AZ or Essai, took, let's say, a 10%-20% stake in Angle for the necessary money?
What if they managed to get away a high interest bond?

outsizeclothes.com
29/4/2024
11:25
Nothing material £££ will come from the AZ deal prior to the cash running out. That’s my view - yours appears to be that we won’t need funding despite the company themselves saying they will.
adw198
29/4/2024
11:20
Bermudashorts - Post Rec your 24086.
gooosed
Chat Pages: 1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  1300  1299  Older

Your Recent History

Delayed Upgrade Clock